Cost-Effectiveness and Cost-Benefit Analyses of Providing Menstrual Cups and Sanitary Pads to Schoolgirls in Rural Kenya.
adolescence
cost-effectiveness analysis
cost–benefit analysis
menstrual cup
menstrual health
randomized trial
sanitary pads
Journal
Women's health reports (New Rochelle, N.Y.)
ISSN: 2688-4844
Titre abrégé: Womens Health Rep (New Rochelle)
Pays: United States
ID NLM: 101768931
Informations de publication
Date de publication:
2022
2022
Historique:
accepted:
01
08
2022
entrez:
3
10
2022
pubmed:
4
10
2022
medline:
4
10
2022
Statut:
epublish
Résumé
To analyze the relative value of providing menstrual cups and sanitary pads to primary schoolgirls. Cost-effectiveness and cost-benefit analyses of three-arm single-site open cluster randomized controlled pilot study providing menstrual cups or sanitary pads for 1 year. Girls 14-16 years of age enrolled across 30 primary schools in rural western Kenya. Cost-effectiveness analysis was conducted based on the health effects (reductions in disability-adjusted life years [DALYs]) and education effects (reductions in school absenteeism) of both interventions. The health and education benefits were separately valued and compared with relative program costs. Compared with the control group, the cost of menstrual cups was estimated at $3,270 per year for 1000 girls, compared with $24,000 for sanitary pads. The benefit of the menstrual cup program (1.4 DALYs averted, 95% confidence interval [CI]: -4.3 to 3.1) was higher compared with a sanitary pad program (0.48 DALYs averted, 95% CI: -4.2 to 2.3), but the health effects of both interventions were not statistically significant likely due to the limited statistical power. Using point estimates, the menstrual cup intervention was cost-effective in improving health outcomes ($2,300/DALY averted). The sanitary pad intervention had a cost-effectiveness of $300/student-school year in reducing school absenteeism. When considering improvements in future earnings from reduced absenteeism, the sanitary pad program had a net benefit of +$68,000 (95% CI: -$32,000 to +$169,000). The menstrual cup may provide a cost-effective solution for menstrual hygiene management in low-income settings. This study outlines a methodology for future analyses of menstrual hygiene interventions and highlights several knowledge gaps that need to be addressed. Trial registration: ISRCTN17486946.
Identifiants
pubmed: 36185073
doi: 10.1089/whr.2021.0131
pii: 10.1089/whr.2021.0131
pmc: PMC9518800
doi:
Types de publication
Journal Article
Langues
eng
Pagination
773-784Subventions
Organisme : Medical Research Council
ID : G1100677
Pays : United Kingdom
Informations de copyright
© Masih A. Babagoli et al., 2022; Published by Mary Ann Liebert, Inc.
Déclaration de conflit d'intérêts
No competing interests to declare.
Références
Lancet Public Health. 2019 Aug;4(8):e376-e393
pubmed: 31324419
BMJ Open. 2016 Nov 23;6(11):e013229
pubmed: 27881530
Int J Environ Res Public Health. 2018 Aug 07;15(8):
pubmed: 30087298
PLoS One. 2016 Dec 21;11(12):e0166122
pubmed: 28002415
Res Microbiol. 2017 Nov - Dec;168(9-10):859-864
pubmed: 28257809
BMJ Open. 2019 Jun 27;9(6):e026186
pubmed: 31248919
Mil Med Res. 2016 Feb 13;3:4
pubmed: 26877884
PLoS Med. 2019 May 16;16(5):e1002803
pubmed: 31095568
PLoS One. 2017 Aug 10;12(8):e0182951
pubmed: 28797115
J Glob Health. 2019 Jun;9(1):010408
pubmed: 30546869
Nature. 2006 Nov 23;444 Suppl 1:59-72
pubmed: 17159895
J Adolesc. 2010 Aug;33(4):521-9
pubmed: 19395018
Bull World Health Organ. 1994;72(3):429-45
pubmed: 8062401
Reprod Health. 2018 Aug 17;15(1):139
pubmed: 30119636
Health Policy Plan. 2006 Sep;21(5):402-8
pubmed: 16877455
BMJ Open. 2017 May 4;7(4):e015429
pubmed: 28473520
BMC Public Health. 2014 Oct 29;14:1118
pubmed: 25355406
Expert Rev Pharmacoecon Outcomes Res. 2013 Oct;13(5):561-3
pubmed: 24090009
J Acquir Immune Defic Syndr. 2000 May 1;24(1):48-56
pubmed: 10877495
PLoS One. 2020 Oct 28;15(10):e0239914
pubmed: 33112868
PLoS One. 2013 Nov 14;8(11):e79132
pubmed: 24244435
Med Decis Making. 2000 Jul-Sep;20(3):332-42
pubmed: 10929856
Lancet. 2012 Dec 15;380(9859):2063-6
pubmed: 23245602
Sex Transm Dis. 2009 Jun;36(6):357-64
pubmed: 19434010
Front Cell Infect Microbiol. 2021 Sep 21;11:716537
pubmed: 34621690
BMC Infect Dis. 2015 Aug 05;15:307
pubmed: 26242185